The Future of excess mortality after COVID-19

<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<rdf:Description>
<dc:creator>Meier, Daniel </dc:creator>
<dc:creator>Patkee, Prachi </dc:creator>
<dc:creator>Strange, Adam </dc:creator>
<dc:creator>Swiss Re Institute</dc:creator>
<dc:date>2024</dc:date>
<dc:description xml:lang="es">Sumario: Quantifying excess mortality has been an acute challenge since 2020 due to the exceptional mortality rates of the pandemic. Excess mortality refers to the number of deaths over and above an assumed expected number of deaths. The different methods of estimating expected mortality can generate very different excess mortality rates. This represents a potential challenge for Life and Health (L&H) insurance, with potentially several years of elevated mortality claims ahead, depending on how general population trends translate into the insured population</dc:description>
<dc:identifier>https://documentacion.fundacionmapfre.org/documentacion/publico/es/bib/186290.do</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>Swiss Re Institute</dc:publisher>
<dc:rights xml:lang="es">InC - http://rightsstatements.org/vocab/InC/1.0/</dc:rights>
<dc:subject xml:lang="es">Mortalidad</dc:subject>
<dc:subject xml:lang="es">COVID-19</dc:subject>
<dc:subject xml:lang="es">Mercado de seguros</dc:subject>
<dc:subject xml:lang="es">Sistemas sanitarios</dc:subject>
<dc:subject xml:lang="es">Seguro de salud</dc:subject>
<dc:subject xml:lang="es">Seguro de vida</dc:subject>
<dc:type xml:lang="es">Books</dc:type>
<dc:title xml:lang="es">The Future of excess mortality after COVID-19</dc:title>
<dc:format xml:lang="es">22 p.</dc:format>
</rdf:Description>
</rdf:RDF>